biotechnology financing the impact of additional patent disclosures for natural product based drug discovery npdd brussels 6 july 2006 stephen m sammut steve net senior fellow wharton health care systems and venture partner burrill & company conference 06 07 2 outline presentation goals speaker s perspective academic research on local industry capability one investor hypothesis global challenges development us european finance market partnering mutual dependence indian example biotech capital interest in emerging markets conclusion issues recommended business alternatives 3 life science entrepreneur since 1975 an originator technology transfer ip management university recent fund formation investments countries such as china india malaysia brazil south africa are pending teams will work situ forming funding companies within country strategy neglected diseases products ability to compete drive activity with american japanese pharmaceutical promote access private public provide entrepreneurial education through newly formed international
